Literature DB >> 12414845

Insulinoma in chronic renal failure: a case report.

Ananda Basu1, Michael T Sheehan, Geoffrey B Thompson, F J Service.   

Abstract

The diagnosis of insulinoma depends on the fulfillment of well-established criteria during the 72-h fast. However, these criteria rely on normal renal function. Spontaneous hypoglycemia that is not attributable to insulinoma may occur in persons with renal failure. We describe herein a patient with renal impairment who had undergone renal transplant and had a 20-yr history of hypoglycemic symptoms and successful resection of insulinoma. Although the results of a 72-h fast were consistent with endogenous hyperinsulinemia, their interpretation was complicated in the presence of renal impairment. Fortunately, the identification of the tumor, by endoscopic ultrasonograph, led to a correct diagnosis. This case seems to be the second report of a patient with insulinoma with concomitant renal failure.

Entities:  

Mesh:

Year:  2002        PMID: 12414845     DOI: 10.1210/jc.2002-020850

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  3 in total

1.  Insulinoma and Chronic Kidney Disease: An Uncommon Conundrum Not to Be Overlooked.

Authors:  Luca Foppiani; Serena Panarello; Marco Filauro; Maria Concetta Scirocco; Stefano Cappato; Andrea Parodi; Simona Sola; Giancarlo Antonucci
Journal:  Clin Med Insights Endocrinol Diabetes       Date:  2017-11-20

2.  Adult Nesidioblastosis in Chronic Kidney Disease.

Authors:  Eduardo Lozano-Melendez; Mercedes Aguilar-Soto; Luis Eugenio Graniel-Palafox; Laura Elena Ceceña-Martínez; Rafael Valdez-Ortiz; Fabio Solis-Jimenez
Journal:  Case Rep Endocrinol       Date:  2019-02-14

3.  Calcium Stimulation Test for Insulinoma Localization in an End-stage Renal Disease Patient on Diazoxide.

Authors:  Stephanie Kim; Miles Conrad; Eunice Chuang; Larry Cai; Umesh Masharani; Elizabeth J Murphy
Journal:  J Endocr Soc       Date:  2020-11-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.